ID: ALA2089303

Max Phase: Preclinical

Molecular Formula: C40H49ClN4O4S

Molecular Weight: 717.38

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CC(C)(C)C(=O)NC12CC3CC(CC(CS(=O)(=O)NC(=O)c4ccc(N5CCN(Cc6ccccc6-c6ccc(Cl)cc6)CC5)cc4)(C3)C1)C2

Standard InChI:  InChI=1S/C40H49ClN4O4S/c1-38(2,3)37(47)42-40-23-28-20-29(24-40)22-39(21-28,26-40)27-50(48,49)43-36(46)31-10-14-34(15-11-31)45-18-16-44(17-19-45)25-32-6-4-5-7-35(32)30-8-12-33(41)13-9-30/h4-15,28-29H,16-27H2,1-3H3,(H,42,47)(H,43,46)

Standard InChI Key:  MTTVLIBAXHYXOO-UHFFFAOYSA-N

Associated Targets(Human)

Apoptosis regulator Bcl-2/Bcl-2 homologous antagonist/killer 28 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 717.38Molecular Weight (Monoisotopic): 716.3163AlogP: 6.89#Rotatable Bonds: 9
Polar Surface Area: 98.82Molecular Species: ACIDHBA: 6HBD: 2
#RO5 Violations: 2HBA (Lipinski): 8HBD (Lipinski): 2#RO5 Violations (Lipinski): 2
CX Acidic pKa: 4.07CX Basic pKa: 8.35CX LogP: 5.67CX LogD: 5.73
Aromatic Rings: 3Heavy Atoms: 50QED Weighted: 0.25Np Likeness Score: -1.07

References

1. Yusuff N, Doré M, Joud C, Visser M, Springer C, Xie X, Herlihy K, Porter D, Touré BB..  (2012)  Lipophilic Isosteres of a π-π Stacking Interaction: New Inhibitors of the Bcl-2-Bak Protein-Protein Interaction.,  (7): [PMID:24900514] [10.1021/ml300095a]

Source